Acertara Acoustic Laboratories has announced that its ultrasound probe testing product, Aureon, has been granted a CE mark. The designation allows for sales and marketing of the product in the European Union.
On July 24, Philips Healthcare, Andover, Mass, announced that FDA has granted 510(k) clearance to market the company’s “ultra-mobile” ultrasound system, VISIQ, in the United States.
NewYork-Presbyterian Hospital (NYP) has announced that it will maintain workspace at a local startup incubator to help foster the hospital’s collaboration with tech entrepreneurs.
The August 15-16 technical conference hosted by the Georgia Biomedical Instrumentation Society in Atlanta will include a 2-day course on maintaining Covidien’s ForceTriad energy platform.
According to Underwriters Laboratories (UL), the FDA has recognized two UL battery safety standards as consensus standards for certain types of medical batteries. The two standards are UL 2504 for Household and Commercial Batteries and UL 1642 for Lithium Batteries (Cells).
At the upcoming annual conference of the Association for Healthcare Resource and Materials Management, Stanley Healthcare will demonstrate the latest release of its SpaceTRAX inventory management system. Changes include improved reporting capabilities, case management, and security features.
IBA has received marketing authorization from the FDA for its Compact Gantry Beam Line. IBA anticipates that this regulatory approval will increase interest in its Proteus ONE proton therapy system.
AAMI has submitted a proposal to the US government to recognize healthcare technology management as a professional field. It has also requested official recognition of the job titles “Clinical Engineer” and “Clinical Systems Engineer.”
The American College of Clinical Engineering (ACCE) will host a 10-part webinar series to review the key topics in the upcoming Certification in Clinical Engineering (CCE) exam. The sessions run on Wednesdays from August 13 to October 15, 2014.
For hospitals deciding whether to outsource some or all of their biomedical services, there is no one-size-fits-all answer.